Posts By: pharmanewsdaily

Innovia Medical acquires surgical instruments manufacturer DTR Medical

Innovia acquisition of DTR Medical : Medical devices manufacturer Innovia Medical has acquired Wales-based DTR Medical, which designs and manufactures single-use surgical instruments for general and specialist surgical procedures. Financial terms of the deal were not disclosed. Established in 2005, DTR Medical started selling its own-branded sterile single-use instruments. In 2007, the Swansea-based surgical instruments […]

Avrobio gets FDA orphan status for AVR-RD-02 in Gaucher disease

US gene therapy company Avrobio has secured orphan-drug designation for AVR-RD-02, its investigational gene therapy, for the treatment of Gaucher disease, from the US Food and Drug Administration (FDA). AVR-RD-02 is made up of the patient’s own hematopoietic stem cells, which are modified genetically to express glucocerebrosidase (GCase), an enzyme that is deficient in Gaucher […]

Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients

Talaris Therapeutics has initiated the phase 3 FREEDOM-1 clinical trial to evaluate its investigational, allogeneic cell therapy FCR001 in living donor kidney transplant (LDKT) recipients. The late-stage clinical trial will assess the safety and efficacy of a single dose of FCR001. The investigational cell therapy has been designed to free LDKT recipients from immunosuppression suppression […]

CMD enrolls first patient in placebo-controlled ALS trial of CuATSM

Collaborative Medicinal Development (CMD) has enrolled the first patient in a placebo-controlled clinical trial to evaluate the safety and efficacy of CuATSM in patients with Amyotrophic Lateral Sclerosis (ALS). The Australian biotech company plans to enroll a total of 80 patients across four clinical sites in Australia. Amyotrophic Lateral Sclerosis is also known as Motor […]

The Pritzker Organization invests in AI-driven Systems Oncology

Systems Oncology, which uses big data and AI to discover scientific insights into cancer biology, has secured an undisclosed investment from the Pritzker Family Business Interests advised by The Pritzker Organization (TPO) during the first closing of its Series B round. The new capital will be used for investing in discovery research and pre-clinical development […]

Janssen bags Stelara FDA approval for ulcerative colitis treatment

Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged approval from the US Food and Drug Administration (FDA) for Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis. Considered to be a serious, chronic and progressive immune-mediated inflammatory disease of the large intestine, […]

Alexion Pharmaceuticals bags Ultomiris FDA approval for atypical HUS

Ultomiris FDA approval : Alexion Pharmaceuticals has bagged approval from the US Food and Drug Administration (FDA) for Ultomiris (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS) in adults and pediatric (one month of age and older) patients. The approval is for the prevention of complement-mediated thrombotic microangiopathy (TMA) in such patient populations. […]

Scroll To Top